Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.

ABSTRACT:

Importance

Increasing numbers of unaffected individuals could benefit from genetic evaluation for inherited cancer susceptibility. Automated conversational agents (ie, chatbots) are being developed for cancer genetics contexts; however, randomized comparisons with standard of care (SOC) are needed.

Objective

To examine whether chatbot and SOC approaches are equivalent in completion of pretest cancer genetic services and genetic testing.

Design, setting, and participants

This equivalence trial (Broadening the Reach, Impact, and Delivery of Genetic Services [BRIDGE] randomized clinical trial) was conducted between August 15, 2020, and August 31, 2023, at 2 US health care systems (University of Utah Health and NYU Langone Health). Participants were aged 25 to 60 years, h

SUBMITTER: Kaphingst KA 

PROVIDER: S-EPMC11385050 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature